Abstract
The hypervariable region 1 (HVR1) of the E2 protein of hepatitis C virus (HCV) is highly heterogeneous in its primary sequence and is responsible for significant inter- and intra-individual variation of the infecting virus, which may represent an important pathogenetic mechanism leading to immune escape and persistent infection. A binding site for neutralizing antibodies (Ab) has also been allegedly identified in this region. Prospective studies of serological responses to synthetic oligopeptides derived from naturally-occurring HVR1 sequences showed promiscuous recognition of HVR1 variants in most patients via binding to C-terminal amino acid residues with conserved physicochemical properties. Monoclonal antibodies generated by immunization of mice with peptides derived from natural HVR1 sequences were shown to recognize several HVR1 variants in line with evidence gathered from studies using human sera. In addition, selected mAbs were able to bind HVR1 in the context of a complete soluble form of the E2 glycoprotein, indicating recognition of correctly folded sequences, and were shown to specifically capture circulating and recombinant HCV particles, suggesting that HVR1 is expressed on intact virus particles and therefore potentially able to interact with cellular receptor(s). These findings suggest that it is possible to induce a broadly reactive clonal immune response to multiple HCV variants and that this mechanism could be used in principle to induce protective immunity for a large repertoire of HCV variants.
Article PDF
Similar content being viewed by others
Abbreviations
- Ab:
-
Antibodies
- HCV:
-
hapatitis C virus
- HVR1:
-
hypervariable region 1
- mAb:
-
monoclonal antibodies
- SRBI:
-
scavenger receptor class B type I
References
Agnello V, Abel G, Elfahal M, Knight G B and Zhang Q X 1999 Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor;Proc. Natl. Acad. Sci. USA 96 12766–12771
Allain J-P, Dong Y, Vandamme A-M, Moulton V and Salemi M 2000 Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters;J. Virol. 74 2541–2549
Bassett S E, Thomas D L, Brasky K M and Lanford R E 1999 Viral persistence antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees;J. Virol. 73 1118–1126
Booth J C L, Kumar U, Webster D, Monjardino J and Thomas H C 1998 Comparison of the rate sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients;Hepatology 27 223–227
Cerino A, Bissolati M, Cividini A, Nicosia A, Esumi M, Hayashi N, Mizuno K, Slobbe R, Oudshoorn P, Silini E, Asti M and Mondelli M U 1997 Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects;J. Med. Virol. 51 1–5
Cerino A, Meola A, Segagni L, Furione M, Marciano S, Triyatni M, Liang T J, Nicosia A and Mondelli M U 2001 Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles;J. Immunol. 167 3878–3886
da Silva-Cardoso M, Simoneit K, Nemecek V, Epple S, Koerner K and Kubanek B 1995 The serology of hepatitis C virus infection: antibody cross-reaction in the hypervariable region 1;Arch. Virol. 140 1705–1713
Del Porto P, Puntoriero G, Scottà C, Nicosia A and Piccolella E 2000 High prevalence of hypervariable region 1-specific and cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment;Virology 269 313–324
Everhart J E, Stolar M and Hoofnagle J H 1997 Management of hepatitis C: a national survey of gastroenterologists and hepatologists;Hepatology 26 78S-82S
Farci P, Alter H J, Govindarajan S, Wang D C, Engle R, Lesniewski R R, Mushahwar I K, Desai S M, Miller R H, Ogata N and Purcell R H 1992 Lack of protective immunity against reinfection with hepatitis C virus;Science 258 135–140
Farci P, Alter H J, Wong D C, Miller R H, Govindarajan S, Engle R, Shapiro M and Purcell R H 1994 Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization;Proc. Natl. Acad. Sci. USA 91 7792–7796
Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpoder J C, Strazzera A, Chien D Y, Munoz S J, Balestrieri A, Purcell R H and Alter H J 2000 The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies;Science 288 339–344
Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter H J and Purcell R H 1996 Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein;Proc. Natl. Acad. Sci. USA 93 15394–15399
Farci P, Strazzera R, Alter H J, Farci S, Degioannis D, Coiana A, Peddis G, Usai F, Serra G, Chessa L, Diaz G, Balestrieri A and Purcell R H 2002 Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome;Proc. Natl. Acad. Sci. USA 99 3081–3086
Flint M, Maidens C L, Loomis-Pric D, Shotton C, Dubuisson J, Monk P, Higginbottom A, Levy S and McKeating J A 1999 Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81;J. Virol. 73 6235–6244
Hamaia S, Li C and Allain J-P 2001 The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines;Blood 98 2293–2300
Hattori M, Yoshioka K, Aiyama T, Iwata K, Terazawa Y, Ishigami M, Yano M and Kakumu S 1998 Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected sera: relation to viral loads and response to interferon;Hepatology 27 1703–1710
Jackson P, Petrik J, Alexander G J M, Pearson G and Allain J P 1997 Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive humam plasma;J. Med. Virol. 51 67–79
Kumar U, Monjardino J and Thomas H C 1994 Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient;Gastroenterology 10 1072–1075
Lesniewsky R R, Boardway K M, Casey J M, Desai S M, Devare S G and Leung T K 1993 Hypervariable region 5’-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants;J. Med. Virol. 40 150–156
Li C, Candotti D and Allain J-P 2001 Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1;J. Virol. 75 12412–12420
Lindebach B D and Rice C M 2001 Flaviviride: the viruses and their replication; inFields virology (eds) D M Knipe and P M Howley (Philadelphia: Lippincott Williams and Wilkins) pp 991–1041
Manzin A, Solforosi L, Debiaggi M, Zara F, Tanzi E, Romano L, Zanetti A R and Clementi M 2000 Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection;J. Virol. 74 4327–4334
Major M E, Mihalik K, Fernandez J, Seidman J, Kleiner D, Kolyhalov A A, Rice C M and Feinstone S M 1999 Longterm follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus;J. Virol. 73 3317–3325
Missale G, Penna A, Boni C, Malpeli M, Zerbini A, Pilli M, Urbani S and Ferrari C 2001 Comparative pathogenesis of HBV and HCV;Virus Res. 82 19–23
Mondelli M U, Cerino A, Lisa A, Brambilla S, Segagni L, Cividini A, Bissolati M, Missale G, Bellati G, Meola A, Bruniercole B, Nicosia A, Galfré G and Silini E 1999 Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation;Hepatology 30 537–545
Patel A, Wood J, Penin F, Dubuisson J and McKeating J 2000 Construction and characterization of chimeric E2 glycoprotein of hepatitis C virus: analysis of E2 regions interacting with CD81;J. Gen. Virol. 81 2873–2883
Penin F, Combet C, Germanidis G, Frainais P-O, Deléage G and Pawlotsky J-M 2001 Conservation of the conformation and positive charges of hepatitis C virus E2 glycoprotein hypervariable region 1 points to a role in cell attachment;J. Virol. 75 5703–5710
Petracca R, Falugi F, Galli G, Norais N, Rosa D, Campagnoli S, Burgio V, di Stasio E, Giardina B, Houghton M, Abrignani S and Grandi G 2000 Structure-function analysis of hepatitis C virus envelope-CD81 binding;J. Virol. 744824–4830
Puntoriero G, Meola A, Lahm A, Zucchelli S, Bruno B, Tafi R, Pezzanera M, Mondelli M U, Cortese R, Tramontano A, Galfrè G and Nicosia A 1998 Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants;EMBO J. 17 3521–3533
Ray C S, Wang Y-M, Laeyendecker O, Ticehurst J R, Villano S A and Thomas D L 1999 Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy;J. Virol. 73 2398–2346
Scarselli E, Ansuini H, Cerino R, Roccasecca R M, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R and Vitelli A 2002 The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus;EMBO J. 21 5017–5025
Scarselli E, Cerino A, Esposito G, Silini E, Mondelli M U and Traboni C 1995 Occurence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable region 1 in hepatitis C viremic patients;J. Virol. 69 4407–4412
Shang D, Zhai W and Allain J-P 1999 Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits;Virology 258 396–405
Shirai M, Arichi T, Chen M, Nishioka M, Ikeda K, Takahashi H, Enomoto N, Saito T, Major M E, Nakazawa T, Akatsuka T, Feinstone S M and Berzofsky J A 1999 T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region;J. Immunol. 162 568–576
Simmonds P 1999 Viral heterogeneity of the hepatitis C virus;J. Hepatol. 31S 54–60
van Doorn L J, Capriles I, Maertens G, DeLeys R, Murray K, Kos T, Schellekens H and Quint W 1995 Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses;J. Virol. 69 773–778
Yoshioka K, Aiyama T, Okumura A, Takayanagi M, Iwata K, Nagai Y and Kakumu S 1997 Humoral immune response to the hypervariable region of hepatitis C virus differs between genotypes 1b and 2a;J. Infect. Dis. 175 505–510
Zibert A, Kraas W, Meisel H, Jung G and Roggendorf M 1997 Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus;J. Virol. 71 4123–4127
Zibert A, Schreier E and Roggendorf M 1995 Antibodies in human sera specific to hypervariable region 1 of hepatitis C can block viral attachment;Virology 208 653–661
Zhou Y H, Shimizu Y K and Esumi M 2000 Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro;Virology 269 276–283
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mondelli, M.U., Cerino, A., Meola, A. et al. Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses. J. Biosci. 28, 305–310 (2003). https://doi.org/10.1007/BF02970149
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02970149